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Background
Patients with hereditary breast cancer constitute a consid-
erable fraction of overall breast cancer sufferers. The con-
tribution of genetic factors to the development of breast
cancer in the admixed and highly consanguineous popula-
tion of the western region of Saudi Arabia is thought to be
significant as the disease is early onset [1]. The current
protocols of continuous clinical follow-up of relatives of
such patients are costly and cause a burden on the usually
over-stretched medical resources. Discovering the signifi-
cant contribution of BRCA1/2 mutations to breast cancer
susceptibility allowed for the design of genetic tests that
allows the medical practitioner to focus the care for those
who need it most. However, BRCA1/2 mutations do not
account for all breast cancer susceptibility genes and there
are other genetic factors, known and unknown that may
play a role in the development of such disease.
Materials and methods
We have performed whole-exome sequencing of seven
cases of breast cancer patients with positive family history
of the disease using the Agilent SureSelect™ Whole-
Exome Enrichment kit and sequencing on the SOLiD™
platform.
Results
In addition to identifying two rare or novel mutations in
BRCA2, we have identified several coding single nucleo-
tide variations that affect genes controlling DNA repair in
the BRCA1/2 pathway. The disruption of these pathways
is very likely to contribute to breast cancer susceptibility.
Conclusions
Our findings suggest that whole exome sequencing is a
powerful tool for identifying mutations associated with
hereditary breast cancer that might be missed by using
other classical genetic testing strategies. Moreover, this
will guide the treatment of breast cancer patients who
have failed to respond to first-line therapies, thus, it is a
great leap towards applying personalized medicine in
Saudi Arabia.
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